Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001209191-16-136817

Options or other derivatives

  • Director acquired 184,562 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Behbahani Ali Director 2016-08-11 Grant or award · Option to purchase Ordinary Shares +184,562 184,562 D
Loading xslF345X03/doc4.xml…